A novel dual endothelin receptor antagonist (ERA), Macitentan, (manufactured by Actelion pharmaceuticals) had been approved for use against Pulmonary…
Articles by Patrícia Silva, PhD
Chronic Thromboembolic Pulmonary Hypertension (CTEPH) has been identified as one of the major causes of acute…
Hypoxia is the clinical manifestation of loss of oxygen supply in the body, leading to difficulty in breathing. Alveolar…
Maxim Petrichuk / Shutterstock.com PoppyPocket founder and CEO, Julie Hydzu, has just announced her commitment…
Pulmonary Hypertension (PH) is a rare condition characterized by increased pressure and constriction of the pulmonary arteries…
A novel concept of targeting the autonomic nervous system around pulmonary arteries and activation of vasointestinal peptides (VIP) to…